{
    "Trade/Device Name(s)": [
        "BD Veritor\u2122 System for Rapid Detection of Flu A + B"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K121797",
    "Predicate Device Reference 510(k) Number(s)": [
        "K053146",
        "K092698"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "June 15, 2012",
    "Summary Letter Received Date": "June 19, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral nucleoprotein antigen",
        "Influenza B viral nucleoprotein antigen"
    ],
    "Specimen Type(s)": [
        "Nasopharyngeal wash/aspirate",
        "Nasopharyngeal swab"
    ],
    "Specimen Container(s)": [
        "Transport media"
    ],
    "Instrument(s)/Platform(s)": [
        "BD Veritor\u2122 System Reader"
    ],
    "Method(s)/Technology(ies)": [
        "Rapid chromatographic immunoassay",
        "Immunochromatographic"
    ],
    "Methodologies": [
        "Antigen detection",
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "System",
        "Test",
        "Reader",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Veritor System for Rapid Detection of Flu A + B utilizing chromatographic immunoassay and electronic reader for detection of influenza A and B antigens in respiratory specimens.",
    "Indications for Use Summary": "Aids in the direct and qualitative detection of influenza A and B viral antigens from nasopharyngeal wash/aspirate and swab samples in transport media from symptomatic patients to diagnose influenza A and B infections; negative results are presumptive and require confirmation.",
    "fda_folder": "Microbiology"
}